Blood biomarkers present in young people with diabetes may indicate they are at higher risk of developing neurodegenerative diseases like Alzheimer’s disease (AD) later in life, according to a new study published in Endocrines.
“Preliminary evidence shows that preclinical [Alzheimer’s disease] neuropathology is present in young people with youth-onset diabetes,” lead study author Allison Shapiro, assistant professor of pediatrics and endocrinology at the University of Colorado School of Medicine, said in a news release. “These preliminary data suggest the potential for an early-onset [Alzheimer’s disease] risk trajectory in people diagnosed with diabetes in childhood or adolescence.”
